MED13 associated with multiple congenital anomalies and a Goldenhar syndrome phenotype

ACMG 2026

Mar 10, 2026
Hereditary
Presentation

Sara Berger, Randee Young, Elizabeth Chao, Andres Morales Corado

Introduction
MED13 plays an important role in regulating transcription and pathogenic variants in this gene are associated with a recently described autosomal dominant neurodevelopmental disorder. Characteristic features include developmental delays, intellectual disability, behavioral differences including autism, seizures, and abnormal brain imaging. Less commonly reported features include mild facial dysmorphism, growth and feeding difficulties, eye anomalies, conductive hearing loss, and congenital heart defects.

 

We report a 10-month-old male with clinical features concerning for Goldenhar syndrome with a de novo pathogenic variant in MED13.

 

Case Presentation
The patient presented with multiple congenital anomalies. Prenatally, a right sided cleft lip and palate were identified. Postnatally, cheek and pre-auricular skin appendages were noted, in addition to bilateral pneumothoraces. Initial impression was Goldenhar syndrome. Ophthalmology exam, renal ultrasound and cervical spine radiographs were normal. Echocardiogram showed a patent foramen ovale and patent ductus arteriosus. Otolaryngology evaluation showed stenotic ear canals with moderate-to-severe bilateral conductive hearing loss.

 

At the time of outpatient evaluation in clinical genetics, repair of the cleft lip and skin appendage removal were complete. There were no concerns regarding development or behavior. Exam was notable for brachycephaly, prominent forehead, mild asymmetry of the face (right>left), single palmar creases bilaterally, and broad first toe bilaterally.

 

Diagnostic Workup

 

Prenatal chromosomes and microarray on amniocytes were negative.

 

At 6-months-old, trio exome sequencing identified a de novo heterozygous pathogenic frameshift variant in MED13 (NM_005121), c.2175dupA; p.H726Tfs*9.

 

Treatment and Management

 

The family received counseling regarding MED13-related neurodevelopmental disorder, emphasizing the limited information available, its’ variable expression and the uncertain relationship with his current phenotype. Follow up with neurology, cardiology, otolaryngology, and ophthalmology was recommended. Reproductive implications and available resources were also discussed.

 

Outcome and Follow-Up

 

Cleft palate repair and myringotomy tube placement was completed without complications.

 

Evaluation by early intervention did not note delays, although he qualified for speech therapy based on his cleft lip and palate. Neurological evaluation noted normal development as of 10-months-old and recommended continued monitoring of development and for seizures.

 

Discussion
Goldenhar syndrome, also called oculo-auriculo-vertebral spectrum or hemifacial microsomia, is characterized by a series of malformations of structures developed from the first and second branchial arches during fetal development, affecting eyes, ears, mouth, maxilla and mandible. Its etiology remains poorly understood, with both environmental and genetic factors implicated.

 

MED13 encodes a component of the Mediator transcription co-activator complex, which plays a key role in regulating gene expression and transcription. Pathogenic variants in several related Mediator complex genes, including MED13L, CDK8, and MED12, have been associated with syndromic conditions. Notably, our patient’s craniofacial features, including cleft palate and brachycephaly, have been more commonly described in individuals with MED13L syndrome.

 

MED13 is primarily associated with differences in neurodevelopment. Our patient does not currently exhibit these features although given his young age, later onset remains possible.

 

This case broadens the phenotypic spectrum of MED13-related neurodevelopmental disorder to include craniofacial features resembling Goldenhar syndrome.

 

Counseling for this case presented challenges. The MED13 pathogenic variant did not fully explain the observed anomalies and introduced new concerns about future neurodevelopment. The limited information available about MED13-related neurodevelopmental disorder, coupled with the lack of molecular testing for Goldenhar syndrome, left the family with more questions than answers.

 

Conclusion
This case suggests a possible expansion of the phenotype associated with MED13, as congenital anomalies are not commonly reported. In addition, this case highlights the importance of counseling for broad genomic testing in infants or children who may have an evolving phenotype.